A single-nucleotide polymorphism-based genome-wide association study that included patients with i-MAD or i-PPNAD not caused by known genetic defects (defects in GNAS or PRKAR1A) showed that abnormalities in genetic loci harboring PDE genes were most likely to be associated with the disease. Here, PRKAR1A is linked to primary pigmented nodular adrenocortical disease.